Previous Section
Review Articles
21. Role of allogeneic transplantation in low-grade lymphoma and chronic lymphocytic leukemia.
- Author
- Thomson KJ; Mackinnon S;
- Institution
- Royal Free and University College Medical School, London, UK. kirsty.thomson@uclh.org
- Journal
- Curr Opin Hematol. 2006 Jul;13(4):273-9.
- Abstract URL
- Click here to view abstract
22. Use of prognostic factors in risk stratification at diagnosis and time of treatment of patients with chronic lymphocytic leukemia.
- Author
- Gowda A; Byrd JC;
- Institution
- Division of Hematology and Oncology, The Ohio State University, Columbus, Ohio 43210, USA.
- Journal
- Curr Opin Hematol. 2006 Jul;13(4):266-72.
- Abstract URL
- Click here to view abstract
23. Immunomodulating drugs for chronic lymphocytic leukaemia.
- Author
- Chanan-Khan A; Porter CW;
- Institution
- Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263, USA. asher.chanan-khan@roswellpark.org
- Journal
- Lancet Oncol. 2006 Jun;7(6):480-8.
- Abstract URL
- Click here to view abstract
24. Genetics, gene expression, and targeted therapies in chronic lymphocytic leukemia.
- Author
- Winkler D; Dohner H; Stilgenbauer S;
- Institution
- Department of Internal Medicine III, University of Ulm, Germany.
- Journal
- Curr Drug Targets. 2006 Oct;7(10):1313-27.
- Abstract URL
- Click here to view abstract
25. Update on risk-stratified management for chronic lymphocytic leukemia.
- Author
- Zent CS; Call TG; Hogan WJ; Shanafelt TD; Kay NE;
- Institution
- Division of Hematology, Mayo Clinic College of Medicine, 200 1st Street SW, Rochester, MN 55905, USA. zent.clive@mayo.edu
- Journal
- Leuk Lymphoma. 2006 Sep;47(9):1738-46.
- Abstract URL
- Click here to view abstract
26. Monoclonal antibodies in chronic lymphocytic leukemia.
- Author
- Ferrajoli A; Faderl S; Keating MJ;
- Institution
- University of Texas MD Anderson Cancer Center, Department of Leukemia, Unit 428, PO Box 301402, Houston, TX 77230-1402, USA. aferrajo@mdanderson.org
- Journal
- Expert Rev Anticancer Ther. 2006 Sep;6(9):1231-8.
- Abstract URL
- Click here to view abstract
27. Narrative review: initial management of newly diagnosed, early-stage chronic lymphocytic leukemia.
- Author
- Shanafelt TD; Byrd JC; Call TG; Zent CS; Kay NE;
- Institution
- Department of Internal Medicine, Division of Hematology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.
- Journal
- Ann Intern Med. 2006 Sep 19;145(6):435-47.
- Abstract URL
- Click here to view abstract
28. Updated guidelines on the management of cytomegalovirus reactivation in patients with chronic lymphocytic leukemia treated with alemtuzumab.
- Author
- O'Brien SM; Keating MJ; Mocarski ES;
- Institution
- Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston , TX 77030, USA. sobrien@mdanderson.org
- Journal
- Clin Lymphoma Myeloma. 2006 Sep;7(2):125-30.
- Abstract URL
- Click here to view abstract
29. The role of hematopoietic stem cell transplantation in Chronic Lymphocytic Leukemia.
- Author
- Banerji V; Johnston JB; Seftel MD;
- Institution
- Section of Haematology, Department of Internal Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.
- Journal
- Transfus Apher Sci. 2007 Aug;37(1):57-62. Epub 2007 Oct 4.
- Abstract URL
- Click here to view abstract
30. Evolving role of monoclonal antibodies in the treatment of chronic lymphocytic leukemia.
- Author
- Kharfan-Dabaja MA; Fahed R; Hussein M; Santos ES;
- Institution
- H. Lee Moffitt Cancer Center and Research Institute, Division of Blood and Marrow Transplantation, 12902 Magnolia Drive, BMT-WCB, Tampa, FL 33612, USA. Kharfama@moffitt.usf.edu
- Journal
- Expert Opin Investig Drugs. 2007 Nov;16(11):1799-815.
- Abstract URL
- Click here to view abstract
